Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery

NCT01229202 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped No REB file

Conditions

Interventions

Sponsor

Nova Scotia Health Authority